BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 17046703)

  • 1. Polypoidal choroidal vasculopathy in tilted disk syndrome and high myopia with staphyloma.
    Mauget-Faÿsse M; Cornut PL; Quaranta El-Maftouhi M; Leys A
    Am J Ophthalmol; 2006 Dec; 142(6):970-5. PubMed ID: 17046703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macular complications on the border of an inferior staphyloma associated with tilted disc syndrome.
    Nakanishi H; Tsujikawa A; Gotoh N; Hayashi H; Iwama D; Tamura H; Otani A; Yoshimura N
    Retina; 2008; 28(10):1493-501. PubMed ID: 18667957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Submacular choroidal neovascularization at the margin of staphyloma in tilted disk syndrome.
    Furuta M; Iida T; Maruko I; Kishi S; Sekiryu T
    Retina; 2013 Jan; 33(1):71-6. PubMed ID: 23269406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic polypoidal choroidal vasculopathy of the macula.
    Moorthy RS; Lyon AT; Rabb MF; Spaide RF; Yannuzzi LA; Jampol LM
    Ophthalmology; 1998 Aug; 105(8):1380-5. PubMed ID: 9709746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy.
    Nishijima K; Takahashi M; Akita J; Katsuta H; Tanemura M; Aikawa H; Mandai M; Takagi H; Kiryu J; Honda Y
    Am J Ophthalmol; 2004 Apr; 137(4):770-3. PubMed ID: 15059729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability.
    Sasahara M; Tsujikawa A; Musashi K; Gotoh N; Otani A; Mandai M; Yoshimura N
    Am J Ophthalmol; 2006 Oct; 142(4):601-7. PubMed ID: 17011852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal pigment epithelial tear in polypoidal choroidal vasculopathy.
    Tsujikawa A; Hirami Y; Nakanishi H; Ojima Y; Aikawa H; Tamura H; Otani A; Yoshimura N
    Retina; 2007 Sep; 27(7):832-8. PubMed ID: 17891005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography.
    Ojima Y; Hangai M; Sakamoto A; Tsujikawa A; Otani A; Tamura H; Yoshimura N
    Retina; 2009 Jan; 29(1):52-9. PubMed ID: 18827738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.
    Lai TY; Lee GK; Luk FO; Lam DS
    Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional and en face optical coherence tomographic features of polypoidal choroidal vasculopathy.
    Saito M; Iida T; Nagayama D
    Retina; 2008 Mar; 28(3):459-64. PubMed ID: 18327139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
    Stangos AN; Gandhi JS; Nair-Sahni J; Heimann H; Pournaras CJ; Harding SP
    Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.
    Saito M; Iida T; Kano M
    Retina; 2011 Sep; 31(8):1589-97. PubMed ID: 21654347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology and long-term changes of choroidal vascular structure in highly myopic eyes with and without posterior staphyloma.
    Moriyama M; Ohno-Matsui K; Futagami S; Yoshida T; Hayashi K; Shimada N; Kojima A; Tokoro T; Mochizuki M
    Ophthalmology; 2007 Sep; 114(9):1755-62. PubMed ID: 17368542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pigment epithelial detachment in polypoidal choroidal vasculopathy.
    Tsujikawa A; Sasahara M; Otani A; Gotoh N; Kameda T; Iwama D; Yodoi Y; Tamura H; Mandai M; Yoshimura N
    Am J Ophthalmol; 2007 Jan; 143(1):102-111. PubMed ID: 17101112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months.
    Hikichi T; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R; Takami K
    Am J Ophthalmol; 2010 Nov; 150(5):674-682.e1. PubMed ID: 20691424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration.
    Chung SE; Kang SW; Lee JH; Kim YT
    Ophthalmology; 2011 May; 118(5):840-5. PubMed ID: 21211846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypoidal choroidal vasculopathy and treatments.
    Gomi F; Tano Y
    Curr Opin Ophthalmol; 2008 May; 19(3):208-12. PubMed ID: 18408495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ueno C; Gomi F; Sawa M; Nishida K
    Retina; 2012; 32(10):2006-13. PubMed ID: 22772392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ricci F; Calabrese A; Regine F; Missiroli F; Ciardella AP
    Retina; 2012 Jul; 32(7):1280-8. PubMed ID: 22218148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy.
    Byeon SH; Lew YJ; Lee SC; Kwon OW
    Acta Ophthalmol; 2010 Sep; 88(6):660-8. PubMed ID: 19563374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.